世界の解剖病理学レポートは、世界市場の包括的な見通しを示すために、市場規模、シェア、売上、予測動向、供給、生産、需要、業界、CAGR などのいくつかの決定的要因を詳細に理解することを重視しています。さらに、このレポートは、「解剖病理学市場」で主要企業が採用している市場の成長と拡大戦略を妨げている課題についても言及しています。
						目次
						
	Contents
	1. Executive Summary
	2. Global Anatomic Pathology Market
	
	2.1. Product Overview
	2.2. Market Definition
	2.3. Segmentation
	2.4. Assumptions and Acronyms
	3. Research Methodology
	
	3.1. Research Objectives
	3.2. Primary Research
	3.3. Secondary Research
	3.4. Forecast Model
	3.5. Market Size Estimation
	4. Average Pricing Analysis
	5. Macro-Economic Indicators
	6. Market Dynamics
	
	6.1. Growth Drivers
	6.2. Restraints
	6.3. Opportunity
	6.4. Trends
	7. Correlation & Regression Analysis
	
	7.1. Correlation Matrix
	7.2. Regression Matrix
	8. Recent Development, Policies & Regulatory Landscape
	9. Risk Analysis
	
	9.1. Demand Risk Analysis
	9.2. Supply Risk Analysis
	10. Global Anatomic Pathology Market Analysis
	
	10.1. Porter Five Forces
	10.1.1. Threat of New Entrants
	10.1.2. Bargaining Power of Suppliers
	10.1.3. Threat of Substitutes
	10.1.4. Rivalry
	10.2. PEST Analysis
	10.2.1. Political
	10.2.2. Economic
	10.2.3. Social
	10.2.4. Technological
	11. Global Anatomic Pathology Market
	
	11.1. Market Size & forecast, 2020A-2031F
	11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12. Global Anatomic Pathology Market: Market Segmentation
	
	12.1. By Regions
	12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.1.5. the Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.2. By Solutions & Services: Market Share (2020-2031F)
	12.2.1. Engagement & Performance Services, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.2.2. Strategic Services, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.2.3. Consulting & Professional Services, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.3. By Application: Market Share (2020-2031F)
	12.3.1. Marketing, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.3.2. Sales, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.3.3. Product Development, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.3.4. Human Resource, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.3.5. Other, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.4. By End-User: Market Share (2020-2031F)
	12.4.1. Banking, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.4.2. Retail, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.4.3. Government, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.4.4. Education, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.4.5. IT & Telecom, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.4.6. Healthcare, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	12.4.7. Others, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
	13. Company Profile
	
	Amos Scientific Pty Ltd.
	Beckton
	Bio SB
	BioGenex
	Bright Instruments
	Cardinal Health
	Cell Signaling Technology Inc.
	CellPath Ltd.
	Danaher Corporation
	Diapath S.p.A
	Dickson and Company
	F. Hoffmann-La Roche AG
	Histo-Line Laboratories
	Hologic Inc.
	Jinhua Yidi Medical Equipment Co. Ltd.
	Laboratory Corporation of America Holdings
	Lupetec
	Medimeas
	MEDITE Medical GmbH
	Merck KGaA
	MICROS AUSTRIA
	Milestone Medical
	NeoGenomics Laboratories Inc.
	PHC Holdings Corporation
	Quest Diagnostics Incorporated
	R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED
	Sakura Finetek
	Sakura Finetek USA, Inc.
	SLEE medical GmbH
	Consultant Recommendation
	
	The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.